CRIS Current Research Information System

SARACINO, ILARIA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.637
NA - Nord America 2.611
EU - Europa 2.520
SA - Sud America 193
AF - Africa 116
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.573
IT - Italia 1.045
SG - Singapore 893
CN - Cina 830
GB - Regno Unito 345
VN - Vietnam 303
SE - Svezia 251
DE - Germania 231
HK - Hong Kong 231
BR - Brasile 159
NL - Olanda 122
IN - India 121
KR - Corea 117
RU - Federazione Russa 105
IE - Irlanda 94
FR - Francia 74
JO - Giordania 49
UA - Ucraina 45
FI - Finlandia 44
ZA - Sudafrica 41
JP - Giappone 34
BG - Bulgaria 33
CI - Costa d'Avorio 26
CA - Canada 25
AT - Austria 23
ID - Indonesia 23
EE - Estonia 21
CH - Svizzera 19
SC - Seychelles 17
ES - Italia 16
AR - Argentina 13
BE - Belgio 11
MX - Messico 9
TG - Togo 9
EC - Ecuador 8
LT - Lituania 7
MA - Marocco 7
PL - Polonia 7
TN - Tunisia 7
BD - Bangladesh 5
GR - Grecia 5
PT - Portogallo 5
TR - Turchia 5
AL - Albania 4
HR - Croazia 4
IQ - Iraq 4
PY - Paraguay 4
CO - Colombia 3
EG - Egitto 3
PE - Perù 3
RO - Romania 3
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
PK - Pakistan 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DK - Danimarca 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TL - Timor Orientale 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.078
Salva come PNG Salva come JPEG
Città #
Singapore 597
Hefei 316
Southend 298
Ashburn 294
Chandler 243
Hong Kong 229
Fairfield 193
Santa Clara 161
Bologna 137
Seoul 117
Dong Ket 108
Woodbridge 107
Princeton 96
Dublin 94
Milan 90
Beijing 87
Boardman 84
Houston 81
Seattle 80
Wilmington 80
Rome 66
Ann Arbor 62
Cambridge 61
Amman 49
Los Angeles 45
New York 40
Ho Chi Minh City 38
Hanoi 36
Turin 35
Sofia 33
Tokyo 33
Berlin 31
Buffalo 31
Redmond 31
Westminster 31
Tappahannock 30
Nanjing 29
Padova 29
Bengaluru 28
Helsinki 27
Abidjan 26
Parma 26
Redondo Beach 24
Jinan 23
Jacksonville 21
Munich 21
Nuremberg 21
Naples 17
Florence 16
Guangzhou 16
Jakarta 16
Lappeenranta 15
São Paulo 15
Yubileyny 15
Dallas 14
San Diego 14
Shenyang 14
Bari 13
Amsterdam 12
Changsha 12
Shanghai 12
Verona 12
Zhengzhou 12
Frattamaggiore 11
Modena 11
Vienna 11
Bern 10
Brussels 10
Chicago 10
Des Moines 10
Hebei 10
Lomé 9
Nanchang 9
Norwalk 9
Saint Petersburg 9
Catania 8
Curitiba 8
Frankfurt am Main 8
Johannesburg 8
Moscow 8
Mülheim 8
Faenza 7
Falkenstein 7
Montreal 7
Offida 7
Shenzhen 7
Tianjin 7
Toronto 7
Bexley 6
Biên Hòa 6
Brescia 6
Council Bluffs 6
Dearborn 6
Ferrara 6
Hải Dương 6
Phoenix 6
Québec 6
Quận Bình Thạnh 6
Trieste 6
Aracaju 5
Totale 4.931
Salva come PNG Salva come JPEG
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 509
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 340
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 249
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 207
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 174
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 166
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 163
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 161
Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results 159
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 154
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 153
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 153
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 149
Therapy for H. pylori: Current concepts 147
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 146
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 137
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 137
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 135
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 134
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 133
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 133
Diagnosi dell'infezione da Helicobacter pylori 129
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 124
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 122
Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models 122
The Bidirectional Link between Nutritional Factors and Inflammatory Bowel Diseases: Dietary Deficits, Habits, and Recommended Interventions-A Narrative Review 120
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 119
Probiotici ricombinanti e loro potenziale sulla salute umana 117
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 117
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 116
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 114
Recombinant probiotics and their potential in human health 114
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 114
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 112
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 111
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 111
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 110
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 107
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 106
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 105
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 103
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 100
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 98
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 97
Gluten-Free Diet and Other Celiac Disease Therapies: Current Understanding and Emerging Strategies 95
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 94
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 93
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 93
Clove Essential Oil as a Source of Antitumoral Compounds Capable of Crossing the Blood–Brain Barrier: A Focus on the Effects of β-Caryophyllene and Eugenol in a Glioblastoma Cell Line 90
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 87
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 87
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 86
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 84
null 81
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 75
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 74
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 69
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 67
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 64
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 64
null 62
Rescue Therapies for H. pylori Infection in Italy 62
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 60
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 56
Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A "Real-World" Open-Label Study on 1585 Patients. 50
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 49
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 49
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 45
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 44
A new non-invasive tool for guiding H. pylori treatment. 43
Antibiotic resistance and therapy for H. Pylori infection in immigrant patients treated in Italy 10
Totale 8.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 16 22 25 44 31 19 186
2021/2022861 78 27 42 84 85 27 28 68 34 35 237 116
2022/20231.073 87 121 69 119 63 82 44 79 234 52 67 56
2023/2024628 29 102 43 76 35 99 32 40 19 52 60 41
2024/20251.980 97 243 155 137 280 124 152 91 64 105 150 382
2025/20262.156 359 449 367 363 387 231 0 0 0 0 0 0
Totale 8.260